American Vanguard (NYSE:AVD) Posts Quarterly Earnings Results, Misses Expectations By $0.60 EPS

American Vanguard (NYSE:AVD) posted its quarterly earnings data on Monday. The basic materials company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.60), Zacks reports. American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%.

American Vanguard Stock Down 15.0%

Shares of NYSE:AVD traded down $0.14 during trading hours on Monday, reaching $0.82. The stock had a trading volume of 730,060 shares, compared to its average volume of 333,527. American Vanguard has a 1 year low of $0.81 and a 1 year high of $5.55. The firm’s 50 day moving average is $1.66 and its 200-day moving average is $2.80. The stock has a market capitalization of $24.13 million, a price-to-earnings ratio of -0.43 and a beta of 1.56. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.40 and a current ratio of 2.47.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on AVD. Wall Street Zen downgraded shares of American Vanguard from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of American Vanguard in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Insider Buying and Selling at American Vanguard

In related news, Director Keith Rosenbloom sold 556,580 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the completion of the transaction, the director owned 15,201 shares in the company, valued at approximately $33,442.20. The trade was a 97.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Steven D. Macicek bought 19,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was acquired at an average cost of $2.09 per share, for a total transaction of $39,710.00. Following the acquisition, the director directly owned 99,711 shares of the company’s stock, valued at $208,395.99. The trade was a 23.54% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 5.60% of the stock is currently owned by insiders.

American Vanguard Company Profile

American Vanguard Corporation, doing business primarily through its AMVAC subsidiary, develops, manufactures and markets specialty agricultural products. The company’s portfolio includes crop protection products such as insecticides, herbicides, fungicides, nematicides and soil fumigants designed to help growers manage pests, weeds and plant diseases.

In addition to crop protection, American Vanguard serves the professional and consumer markets for turf and ornamental care, golf course management, pest control and public health.